Britannia Life Sciences Inc. (CSE:BLAB)

Britannia Life Sciences Statistics

Total Valuation

CSE:BLAB has a market cap or net worth of CAD 16.23 million. The enterprise value is 11.91 million.

Market Cap	16.23M
Enterprise Value	11.91M

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:BLAB has 162.25 million shares outstanding.

Current Share Class	162.25M
Shares Outstanding	162.25M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.78%
Owned by Institutions (%)	n/a
Float	102.58M

Valuation Ratios

The trailing PE ratio is 2.18.

PE Ratio	2.18
Forward PE	n/a
PS Ratio	42.33
PB Ratio	2.93
P/TBV Ratio	2.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.60
EV / Sales	31.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.33.

Current Ratio	3.09
Quick Ratio	2.40
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21.80

Financial Efficiency

Return on equity (ROE) is -73.71% and return on invested capital (ROIC) is -13.69%.

Return on Equity (ROE)	-73.71%
Return on Assets (ROA)	-8.90%
Return on Invested Capital (ROIC)	-13.69%
Return on Capital Employed (ROCE)	-31.31%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +150.00% in the last 52 weeks. The beta is -0.03, so CSE:BLAB's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	+150.00%
50-Day Moving Average	0.09
200-Day Moving Average	0.07
Relative Strength Index (RSI)	53.85
Average Volume (20 Days)	66,656

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BLAB had revenue of CAD 383,303 and earned 7.44 million in profits. Earnings per share was 0.05.

Revenue	383,303
Gross Profit	-43,359
Operating Income	-2.24M
Pretax Income	-4.34M
Net Income	7.44M
EBITDA	-2.14M
EBIT	-2.24M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 6.14 million in cash and 1.82 million in debt, giving a net cash position of 4.32 million or 0.03 per share.

Cash & Cash Equivalents	6.14M
Total Debt	1.82M
Net Cash	4.32M
Net Cash Per Share	0.03
Equity (Book Value)	5.55M
Book Value Per Share	0.03
Working Capital	5.51M

Cash Flow

Operating Cash Flow	-3.78M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -11.31%, with operating and profit margins of -585.55% and 1,941.02%.

Gross Margin	-11.31%
Operating Margin	-585.55%
Pretax Margin	-1,132.23%
Profit Margin	1,941.02%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	45.85%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 18, 2021
Split Type	Reverse
Split Ratio	0.1

Scores

CSE:BLAB has an Altman Z-Score of -0.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.61
Piotroski F-Score	3